MARKET RADAR
SENSEX     NIFTY      Refresh

SBI Magnum Pharma Fund (G)

48.700
0.01 (0.02%)
NAV as on May-25-2012

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on May-25-2012)

Period Returns (%) Rank #
1 mth -1.4 1
3 mth 7.8 1
6 mth 10.3 1
1 year 10.3 1
2 year 12.7 1
3 year 25.5 2
5 year 6.6 3

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2012 9.4 - - - -
2011 -6.1 6.8 -8.3 2.9 -5.6
2010 4.6 9.8 -0.3 9.5 29.6
2009 -11.3 43.8 26.2 -0.2 81.2
2008 -27.0 6.7 -10.5 -27.8 -50.2
2007 -7.3 12.9 -9.7 11.7 5.6

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -1.4 7.8 10.3 10.3 12.7 25.5 6.6
Category avg -2.3 5.8 7.2 5.1 9.8 27.1 12.9
Difference of Fund returns and Category returns 0.9 2.0 3.1 5.2 2.9 -1.6 -6.3
Best of category -1.4 7.8 10.3 10.3 12.7 31.8 19.9
Worst of category -2.8 3.5 3.1 1.5 7.9 23.9 6.6
Benchmark returns # -1.9 6.3 11.9 10.0 12.7 24.1 12.1
Difference of Fund returns and Benchmark returns 0.5 1.5 -1.6 0.3 0.0 1.4 -5.5
# Benchmark Index: BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jul 31, 1999
Benchmark BSE HEALTHCARE
Asset Size (Rs cr) 41.05 (Mar-31-2012)
Minimum Investment Rs.2000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Tanmaya Desai
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment.

Contact Details

Regd. Office 191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No. 91 22 22180221/ 27
Fax No. 91 22 22189663
Email partnerforlife@sbimf.com
Website http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
563.56 6.0 8.1 3.4 31.8 19.9
SBI Magnum Pharma Fund (G) Not Ranked
41.05 7.8 10.3 10.3 25.5 6.6
UTI Pharma & Health (G) Not Ranked
93.37 3.5 3.1 1.5 23.9 12.3
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Apr 30, 12)

Equity Sector Value
(Rs cr)
Asset %
Dr Reddys Labs Pharmaceuticals - 14.31
Cipla Pharmaceuticals - 10.86
Divis Labs Pharmaceuticals - 9.94
Lupin Pharmaceuticals - 9.87
Cadila Health Pharmaceuticals - 8.96
Ipca Labs Pharmaceuticals - 7.02
Torrent Pharma Pharmaceuticals - 6.79
Wyeth Pharmaceuticals - 6.26
Sun Pharma Pharmaceuticals - 4.90
Novartis India Pharmaceuticals - 3.28

Full Portfolio

Sector Allocation (Apr 30, 12)

Sector %

1-Year

HighLow

Pharmaceuticals 94.25 98.60 90.13

View All Sectors

Asset Allocation (%)(Apr 30, 12)

Equity 94.25
Others 0.00
Debt 0.00
Mutual Funds N.A
Money Market 0.00
Cash / Call 5.75

View All

Concentration

Holdings (%)
Top 5 53.94
Top 10 82.19
Sector (%)
Top 3 94.25

News & Videos

Messages & Community